We assess what is working and whats not to establish a plan for the patient, said Roberto Miranda M.D., a family medicine provider with MUSC Health Pee Dee Primary Care and an expert on the subject of obesity medications
and achievement of weight loss of 5%, 10%, 15% and 20% at week 52

Food and Drug Administration (2023) Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial, JAMA (2022) Liraglutide versus semaglutide for weight reduction-A cost needed to treat analysis, Obesity (2023) Impact of liraglutide on amylase, lipase, and acute pancreatitis in participants with overweight/obesity and normoglycemia, prediabetes, or Type 2 diabetes: secondary analyses of pooled data from the SCALE clinical development program, Diabetes Care (2017) Hypoglycemia, Endocrine Society (2022) Wegovy drug label information, DailyMed (2023) Saxenda drug label information, DailyMed (2023) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) What to know about popular weight loss meds, Texas Health (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

S.MilutinoviM.BrankoviS.Mihajilov-KrstevT.RandjeloviM.MiladinoviB.et al (2024)